title: Right atrial thrombosis in systemic lupus erythematosus.
authors.forename: A
authors.initials: A
authors.lastname: Vacca
authors.forename: P
authors.initials: P
authors.lastname: Garau
authors.forename: L
authors.initials: L
authors.lastname: Meloni
authors.forename: R
authors.initials: R
authors.lastname: Montisci
authors.forename: A
authors.initials: A
authors.lastname: Mameli
authors.forename: G
authors.initials: G
authors.lastname: Passiu
authors.forename: A
authors.initials: A
authors.lastname: Mathieu
mesh_terms: D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use; D002405:Catheterization, Central Venous / Q000009:adverse effects; D003328:Coronary Thrombosis / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D017548:Echocardiography, Transesophageal; D005260:Female; D006325:Heart Atria / Q000000981:diagnostic imaging / Q000473:pathology*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000473:pathology / Q000628:therapy; D008775:Methylprednisolone / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D020551:Pulse Therapy, Drug; D016896:Treatment Outcome
chemical_list: D000925:Anticoagulants; D003520:Cyclophosphamide; D006493:Heparin; D011241:Prednisone; D008775:Methylprednisolone